Acrivon Therapeutics, Inc.
ACRV
$1.62
$0.095.88%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.74% | -19.38% | -14.02% | 14.37% | -33.08% |
| Total Depreciation and Amortization | 20.72% | 10.09% | 1.79% | 50.34% | 12.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.95% | 0.26% | -9.86% | 16.29% | -4.17% |
| Change in Net Operating Assets | -2.26% | 9.79% | 151.71% | -191.52% | 125.99% |
| Cash from Operations | -0.21% | -24.60% | 18.61% | -38.14% | -26.11% |
| Capital Expenditure | 16.38% | -621.90% | 83.19% | 29.19% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -10.36% | 119.34% | -1,418.93% | -69.27% | 1,330.54% |
| Cash from Investing | -9.99% | 118.19% | -1,605.03% | -71.51% | 1,254.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | 88,517.72% | -75.16% | 307.69% |
| Repurchase of Common Stock | 45.95% | -134.71% | -207.23% | 87.20% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -100.57% | 63,455.29% | 91.76% | -- |
| Cash from Financing | 56.98% | -101.22% | 71,815.12% | 91.45% | -2,678.21% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -27.66% | -113.16% | 287.66% | -285.18% | 175.00% |
